EDEN PRAIRIE, Minn. , Jan. 24, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced it will be sponsoring a breakfast symposium at the Society of Thoracic Surgeons Annual Meeting, featuring Daniel Beckles , M.D., Ph.D., on Monday, January 28, 2019 , at the Marriott Marquis in San
EDEN PRAIRIE, Minn. , Jan. 16, 2019 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS) today announced the filing of two new patent applications with the United States Patent and Trademark Office (USPTO) designed to deepen the company’s intellectual property protection for its Aquadex FlexFlow
EDEN PRAIRIE, Minn. , Dec. 05, 2018 (GLOBE NEWSWIRE) -- CHF Solutions (Nasdaq: CHFS), today announced that it will be exhibiting at Heart Failure University from December 7-9, 2018 at the Los Angeles Airport Marriott , Los Angeles, Calif. “Heart Failure University is a unique venue as cardiology
CHF Solutions to Present at the 11th Annual LD Micro Main Event Eden Prairie, Minn. / ACCESSWIRE / November 28, 2018 / CHF Solutions (Nasdaq: CHFS), today announced that it will be presenting at the 11 th annual LD Micro Main Event on Wednesday, December 5 th at 7:30AM PST /10:30AM EST.
EDEN PRAIRIE, Minn. , Nov. 15, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS), today announces the launch of its new educational webinar featuring Daniel Beckles , M.D., Ph.D., director of Minimally Invasive Cardiothoracic Surgery at UHS Heart and Vascular Institute , Vestal, N.Y. The
EDEN PRAIRIE, Minn. , Nov. 09, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) today announced that on November 8, 2018 , the independent directors approved four equity awards under CHF Solution’s New-Hire Equity Incentive Plan, as material inducements to four individuals entering into
EDEN PRAIRIE, Minn. , Nov. 08, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (Nasdaq: CHFS), today announced that it will release an educational webinar featuring the clinical use of the Aquadex FlexFlow system following cardiovascular surgery in patients who have failed diuretic therapy. The
EDEN PRAIRIE, Minn. , Nov. 06, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announced today its third quarter results for the period ended September 30 , 2018. Highlights include: Revenue for third quarter ended September 30, 2018 increased 42 percent compared to the same period in
EDEN PRAIRIE, Minn. , Nov. 01, 2018 (GLOBE NEWSWIRE) -- CHF Solutions , Inc. (Nasdaq: CHFS) announced today that it has entered into a collaboration agreement with Daxor Corporation (NYSE:DXR) to explore potential synergies between the company’s Aquadex FlexFlow ® System and Daxor’s BVA-100 Blood
EDEN PRAIRIE, Minn. , Oct. 30, 2018 (GLOBE NEWSWIRE) -- CHF Solutions, Inc. (NASDAQ: CHFS) announces today that its third quarter 2018 financial results will be released on Tuesday, November 6, 2018 . The company will host a conference call and webcast at 9:00 AM EST that morning, during which